Stereotactic Body Radiotherapy Plus Rucosopasem in Locally Advanced or Borderline Resectable Pancreatic Cancer: GRECO-2 Phase II Study Design

Sarah E Hoffe1 H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL33612, USACorrespondence[email protected]

Todd A Aguilera2 UT Southwestern Medical Center, Dallas, TX75390, USA

Parag J Parikh3 Henry Ford Cancer Institute, Detroit, MI48202, USA

Maged M Ghaly4 Northwell Health Cancer Institute, New Hyde Park, NY11040, USA

Joseph M Herman4 Northwell Health Cancer Institute, New Hyde Park, NY11040, USA

Joseph M Caster5 Universty of Iowa Hospitals & Clinics, Iowa City, IA52242, USA

Dae Won Kim1 H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL33612, USA

James Costello1 H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL33612, USA

Mokenge P Malafa1 H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL33612, USA

Elizabeth C Moser6 Galera Therapeutics, Inc., Malvern, PA19355, USA

Eugene P Kennedy6 Galera Therapeutics, Inc., Malvern, PA19355, USA

Kara Terry6 Galera Therapeutics, Inc., Malvern, PA19355, USA

Michael Kurman6 Galera Therapeutics, Inc., Malvern, PA19355, USA

Your download is now in progress and you may close this window